Takara Bio Inc operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Takara Bio Inc with three other
companies in this sector in Japan:
Sosei Group Corporation
sales of 18.90 billion Japanese Yen [US$170.11 million]
of which 99%
was Overseas Pharmaceutical Business),
Shin Nippon Biomedical Laboratories Ltd
(17.24 billion Japanese Yen [US$155.20 million]
of which 75%
was Pre-Clinical Business), and
Morishita Jintan Co., Ltd.
(10.97 billion Japanese Yen [US$98.70 million]
of which 71%
was Health Care Business).
Takara Bio Inc reported sales of ¥29.38 billion (US$264.38 million)
March of 2017.
decrease of 1.2%
versus 2016, when the company's sales were ¥29.73 billion.
Contributing to the drop in overall sales was the 4.4% decline
in Food and Bio Medical, from ¥2.41 billion to ¥2.30 billion.
There were also decreases in sales in
Bio Support (down 2.7% to ¥26.57 billion)